Burçe Göktaş

2PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 21, 2022
An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction.

İrfan Cicin, Mohammed Oukkal, Hassen Mahfouf

|Aug 21, 2018
Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study.

Tülay Canda, Ekrem Yavuz, Necmettin Özdemir

Pageof 1

Frequent Collaborators

1 joint publications

Tülay Canda

1 joint publications

Ekrem Yavuz

1 joint publications

Necmettin Özdemir

1 joint publications

Sennur İlvan